Daniel is a founding executive at Organon, where he serves as EVP of Corporate Development and Chief Strategy Officer. An alumnus of The Wharton School and Duke University, he has executed over $83 billion in transactions, focusing on bringing innovative drugs, therapies, and vaccines to patients.
He appears to be family-oriented, having shared his experience of bringing his daughter and son to a company work day. He finds inspiration in seeing his professional mission to create a healthier future through the eyes of his children, connecting his work to the next generation.
Unique fact: Daniel built and leads Organons global business development, including M&A, licensing, and integration, since the companys inception.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.